EC chi hơn 70 triệu USD mua thuốc remdesivir điều trị COVID-19

(TTXVN/Vietnam+) 08:49 30/07/2020

Nhằm đáp ứng nhu cầu cấp bách hiện nay cho các bệnh nhân mắc dịch viêm đường hô hấp cấp COVID-19 ở châu Âu, ngày 29/7, Ủy ban châu Âu (EC) thông báo đã đồng ý mua thuốc kháng virus remdesivir vốn khan hiếm của công ty dược phẩm Mỹ Gilead Sciences.

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